EC chi hơn 70 triệu USD mua thuốc remdesivir điều trị COVID-19

(TTXVN/Vietnam+) 08:49 30/07/2020

Nhằm đáp ứng nhu cầu cấp bách hiện nay cho các bệnh nhân mắc dịch viêm đường hô hấp cấp COVID-19 ở châu Âu, ngày 29/7, Ủy ban châu Âu (EC) thông báo đã đồng ý mua thuốc kháng virus remdesivir vốn khan hiếm của công ty dược phẩm Mỹ Gilead Sciences.

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